EC chi hơn 70 triệu USD mua thuốc remdesivir điều trị COVID-19

(TTXVN/Vietnam+) 08:49 30/07/2020

Nhằm đáp ứng nhu cầu cấp bách hiện nay cho các bệnh nhân mắc dịch viêm đường hô hấp cấp COVID-19 ở châu Âu, ngày 29/7, Ủy ban châu Âu (EC) thông báo đã đồng ý mua thuốc kháng virus remdesivir vốn khan hiếm của công ty dược phẩm Mỹ Gilead Sciences.

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